EC chi hơn 70 triệu USD mua thuốc remdesivir điều trị COVID-19

(TTXVN/Vietnam+) 08:49 30/07/2020

Nhằm đáp ứng nhu cầu cấp bách hiện nay cho các bệnh nhân mắc dịch viêm đường hô hấp cấp COVID-19 ở châu Âu, ngày 29/7, Ủy ban châu Âu (EC) thông báo đã đồng ý mua thuốc kháng virus remdesivir vốn khan hiếm của công ty dược phẩm Mỹ Gilead Sciences.

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